In short, tear S100A6 and MMP-9 are elevated in SS patients, albeit to a different extent, which ratifies the diagnostic potential of these biomarkers as their presence is enhanced in conditions of ocular surface inflammation, as described previously [28,37,38]. This evidence concerns the gene MMP9 and synovial sarcoma.